FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Fate Therapeutics
Fate Therapeutics
Neonc Technologies, Inc.
Pfizer
Shanghai Junshi Bioscience Co., Ltd.
GI Innovation, Inc.
National University Hospital, Singapore